↓ Skip to main content

Cochrane Database of Systematic Reviews

Treatment for amphetamine psychosis

Overview of attention for article published in Cochrane database of systematic reviews, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
4 tweeters
wikipedia
23 Wikipedia pages

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
195 Mendeley
Title
Treatment for amphetamine psychosis
Published in
Cochrane database of systematic reviews, January 2009
DOI 10.1002/14651858.cd003026.pub3
Pubmed ID
Authors

Steven J Shoptaw, Uyen Kao, Walter Ling

Abstract

Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 <1%
United States 1 <1%
Australia 1 <1%
Switzerland 1 <1%
Unknown 191 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 31 16%
Student > Master 28 14%
Researcher 23 12%
Student > Ph. D. Student 22 11%
Student > Postgraduate 13 7%
Other 34 17%
Unknown 44 23%
Readers by discipline Count As %
Medicine and Dentistry 61 31%
Psychology 29 15%
Nursing and Health Professions 15 8%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Social Sciences 7 4%
Other 22 11%
Unknown 49 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 June 2022.
All research outputs
#1,390,484
of 22,046,823 outputs
Outputs from Cochrane database of systematic reviews
#3,270
of 12,173 outputs
Outputs of similar age
#15,126
of 284,879 outputs
Outputs of similar age from Cochrane database of systematic reviews
#135
of 458 outputs
Altmetric has tracked 22,046,823 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,173 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.9. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 284,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 458 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.